Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi‐active components combination

The antitumor efficacy of Chinese herbal medicines has been widely recognized. Leading compounds such as sterols, glycosides, flavonoids, alkaloids, terpenoids, phenylpropanoids, and polyketides constitute their complex active components. The antitumor monomers derived from Chinese medicine possess...

Full description

Saved in:
Bibliographic Details
Published inMedicinal research reviews Vol. 43; no. 5; pp. 1778 - 1808
Main Authors Zhao, Wei, Zheng, Xiao‐Di, Tang, Paula Yun‐Zhi, Li, Hong‐Mei, Liu, Xue, Zhong, Jian‐Jiang, Tang, Ya‐Jie
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.09.2023
Subjects
active components
Alkaloids
Antineoplastic Agents - pharmacology
antitumor drug
Cancer
drugs combination
Drugs, Chinese Herbal - adverse effects
Flavonoids
Herbal medicine
Humans
Medicine, Chinese Traditional
R&D
Research & development
Traditional Chinese medicine
traditional Chinese medicine
antitumor drug
drugs combination
active components
Online AccessGet full text

Cover

Abstract The antitumor efficacy of Chinese herbal medicines has been widely recognized. Leading compounds such as sterols, glycosides, flavonoids, alkaloids, terpenoids, phenylpropanoids, and polyketides constitute their complex active components. The antitumor monomers derived from Chinese medicine possess an attractive anticancer activity. However, their use was limited by low bioavailability, significant toxicity, and side effects, hindering their clinical applications. Recently, new chemical entities have been designed and synthesized by combining natural drugs with other small drug molecules or active moieties to improve the antitumor activity and selectivity, and reduce side effects. Such a novel conjugated drug that can interact with several vital biological targets in cells may have a more significant or synergistic anticancer activity than a single‐molecule drug. In addition, antitumor conjugates could be obtained by combining pharmacophores containing two or more known drugs or leading compounds. Based on these studies, the new drug research and development could be greatly shortened. This study reviews the research progress of conjugates with antitumor activity based on Chinese herbal medicine. It is expected to serve as a valuable reference to antitumor drug research and clinical application of traditional Chinese medicine.
AbstractList The antitumor efficacy of Chinese herbal medicines has been widely recognized. Leading compounds such as sterols, glycosides, flavonoids, alkaloids, terpenoids, phenylpropanoids, and polyketides constitute their complex active components. The antitumor monomers derived from Chinese medicine possess an attractive anticancer activity. However, their use was limited by low bioavailability, significant toxicity, and side effects, hindering their clinical applications. Recently, new chemical entities have been designed and synthesized by combining natural drugs with other small drug molecules or active moieties to improve the antitumor activity and selectivity, and reduce side effects. Such a novel conjugated drug that can interact with several vital biological targets in cells may have a more significant or synergistic anticancer activity than a single‐molecule drug. In addition, antitumor conjugates could be obtained by combining pharmacophores containing two or more known drugs or leading compounds. Based on these studies, the new drug research and development could be greatly shortened. This study reviews the research progress of conjugates with antitumor activity based on Chinese herbal medicine. It is expected to serve as a valuable reference to antitumor drug research and clinical application of traditional Chinese medicine.
The antitumor efficacy of Chinese herbal medicines has been widely recognized. Leading compounds such as sterols, glycosides, flavonoids, alkaloids, terpenoids, phenylpropanoids, and polyketides constitute their complex active components. The antitumor monomers derived from Chinese medicine possess an attractive anticancer activity. However, their use was limited by low bioavailability, significant toxicity, and side effects, hindering their clinical applications. Recently, new chemical entities have been designed and synthesized by combining natural drugs with other small drug molecules or active moieties to improve the antitumor activity and selectivity, and reduce side effects. Such a novel conjugated drug that can interact with several vital biological targets in cells may have a more significant or synergistic anticancer activity than a single-molecule drug. In addition, antitumor conjugates could be obtained by combining pharmacophores containing two or more known drugs or leading compounds. Based on these studies, the new drug research and development could be greatly shortened. This study reviews the research progress of conjugates with antitumor activity based on Chinese herbal medicine. It is expected to serve as a valuable reference to antitumor drug research and clinical application of traditional Chinese medicine.The antitumor efficacy of Chinese herbal medicines has been widely recognized. Leading compounds such as sterols, glycosides, flavonoids, alkaloids, terpenoids, phenylpropanoids, and polyketides constitute their complex active components. The antitumor monomers derived from Chinese medicine possess an attractive anticancer activity. However, their use was limited by low bioavailability, significant toxicity, and side effects, hindering their clinical applications. Recently, new chemical entities have been designed and synthesized by combining natural drugs with other small drug molecules or active moieties to improve the antitumor activity and selectivity, and reduce side effects. Such a novel conjugated drug that can interact with several vital biological targets in cells may have a more significant or synergistic anticancer activity than a single-molecule drug. In addition, antitumor conjugates could be obtained by combining pharmacophores containing two or more known drugs or leading compounds. Based on these studies, the new drug research and development could be greatly shortened. This study reviews the research progress of conjugates with antitumor activity based on Chinese herbal medicine. It is expected to serve as a valuable reference to antitumor drug research and clinical application of traditional Chinese medicine.
Author Zhao, Wei
Zheng, Xiao‐Di
Zhong, Jian‐Jiang
Li, Hong‐Mei
Liu, Xue
Tang, Ya‐Jie
Tang, Paula Yun‐Zhi
Author_xml – sequence: 1
  givenname: Wei
  surname: Zhao
  fullname: Zhao, Wei
  organization: Shandong University
– sequence: 2
  givenname: Xiao‐Di
  surname: Zheng
  fullname: Zheng, Xiao‐Di
  organization: Hubei University of Technology
– sequence: 3
  givenname: Paula Yun‐Zhi
  surname: Tang
  fullname: Tang, Paula Yun‐Zhi
  organization: Jinan Zhensheng School
– sequence: 4
  givenname: Hong‐Mei
  surname: Li
  fullname: Li, Hong‐Mei
  organization: Shandong University
– sequence: 5
  givenname: Xue
  surname: Liu
  fullname: Liu, Xue
  organization: Jinan Intellectual Property Protection Center
– sequence: 6
  givenname: Jian‐Jiang
  surname: Zhong
  fullname: Zhong, Jian‐Jiang
  organization: Shanghai Jiao Tong University
– sequence: 7
  givenname: Ya‐Jie
  orcidid: 0000-0002-8342-5201
  surname: Tang
  fullname: Tang, Ya‐Jie
  email: yajietang@sdu.edu.cn
  organization: Shandong University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37183170$$D View this record in MEDLINE/PubMed
BookMark eNp1kb1uFDEUhS0URDaBghdAlmig2MQ_8-MpoyWQSEE0UI889p3gaMZe_LPRdrwBPCNPwt3spomg8pH8nWPfc0_IkQ8eCHnN2RlnTJzPYM8E7xr5jCw469SSc6GOyIJx1I0U9TE5SemOMc5rLl-QY9lyJXnLFuTXhd1obyDRMFLts8tlDpHaWG6pdcmEDcQtdZ7mqK3LLng90dV35yEBxXedQYlGS73OJeKlNtltgK5jsMXkRIctLcn5WzqXKbs_P38fABPmNY7hEUE5OPRj-kvyfNRTgleH85R8-3j5dXW1vPny6Xp1cbM0spZy2SjRNHKsGwad1YMF0J02TBqmeS3Hqq4kCANiqEWlqlE2bSUtjFyNUlWgBnlK3u1z8Z8_CqTczzgtTJP2EErqheJSqQ5tiL59gt6FErGHHVU1qm2Z2FFvDlQZsJd-Hd2s47Z_rBqB8z1gYkgpwtgblx9mxmrd1HPW75bZ78wPy0TH-yeOx9B_sYf0ezfB9v9g__nyw97xF9EmsUY
CitedBy_id crossref_primary_10_1016_j_jep_2023_117211
crossref_primary_10_1002_smll_202311571
crossref_primary_10_1016_j_ejphar_2024_177221
crossref_primary_10_1016_j_jep_2025_119479
crossref_primary_10_1016_j_bse_2024_104880
crossref_primary_10_1016_j_cclet_2023_109450
crossref_primary_10_12677_HJMCe_2024_121009
crossref_primary_10_1016_j_jep_2024_118265
crossref_primary_10_2147_IJN_S455407
crossref_primary_10_2147_IJN_S508767
crossref_primary_10_1021_acsomega_3c08320
crossref_primary_10_1002_cbdv_202401426
crossref_primary_10_1021_acs_jnatprod_3c01040
crossref_primary_10_1002_INMD_20240010
crossref_primary_10_1007_s11101_024_10015_3
crossref_primary_10_1016_j_mtbio_2025_101611
crossref_primary_10_1155_2024_8843855
crossref_primary_10_1016_j_chroma_2024_465288
crossref_primary_10_1016_j_jpha_2024_101157
crossref_primary_10_3389_fimmu_2025_1529710
crossref_primary_10_1002_slct_202402411
crossref_primary_10_3389_fphar_2024_1438259
crossref_primary_10_3892_etm_2024_12737
crossref_primary_10_1016_S1875_5364_24_60741_7
crossref_primary_10_1021_acs_jafc_4c04961
crossref_primary_10_1016_j_polymer_2024_127121
crossref_primary_10_1055_a_2188_3718
crossref_primary_10_1021_acs_orglett_4c03358
crossref_primary_10_1186_s12951_024_03084_1
crossref_primary_10_1134_S1068162024020110
crossref_primary_10_3389_fphar_2024_1498339
crossref_primary_10_3390_molecules29174193
crossref_primary_10_1186_s43066_023_00306_3
Cites_doi 10.1016/j.ccell.2016.02.011
10.1021/acs.jmedchem.8b01946
10.1016/j.bmcl.2017.01.080
10.1021/ml500394m
10.3389/fphar.2016.00201
10.1080/14756366.2018.1510919
10.1038/onc.2011.384
10.1056/NEJMoa065044
10.1038/nrm.2017.53
10.1186/1471-2407-10-370
10.1016/j.bmcl.2012.05.019
10.1021/acs.jmedchem.8b01755
10.2174/1871520610909040397
10.2165/00003495-199549060-00007
10.1021/acsomega.0c00558
10.1038/nrclinonc.2018.28
10.1016/j.ejmech.2017.07.011
10.1016/j.phrs.2016.03.012
10.1021/acs.jnatprod.7b01012
10.1021/mp500180e
10.1021/jm501573b
10.1016/j.bmcl.2007.01.090
10.1002/jcph.2128
10.1016/j.ejmech.2016.10.068
10.1016/j.bioorg.2011.07.004
10.1021/jm900610k
10.1007/s002800000133
10.1016/j.phytochem.2011.12.022
10.1002/minf.201300182
10.1016/j.compbiolchem.2018.12.003
10.1016/j.bmc.2016.12.019
10.1097/CAD.0b013e32835a36db
10.1016/j.indcrop.2016.03.024
10.1016/j.ejmech.2016.12.046
10.2174/138955707782795647
10.1016/j.ejmech.2017.09.074
10.1016/j.ejmech.2014.09.055
10.2174/1568026619666190619115735
10.1002/ardp.201600369
10.1021/acsomega.7b01784
10.1039/C6MD00297H
10.2174/092986710793361252
10.1155/2018/3271948
10.1021/jm801331y
10.1111/j.1600-079X.2005.00229.x
10.1073/pnas.81.13.4090
10.3390/cancers12061523
10.1039/C6BM00800C
10.5306/wjco.v2.i2.80
10.1016/j.jmb.2004.03.077
10.3390/molecules23071616
10.1016/j.bmcl.2018.03.009
10.1016/j.saa.2017.12.063
10.1021/acs.jmedchem.9b01223
10.1016/j.bmcl.2016.04.034
10.1039/D0NP00041H
10.1186/s13148-015-0157-2
10.1021/acs.jmedchem.9b01736
10.1080/14786419.2020.1834546
10.1021/acsomega.0c01703
10.1016/j.bbrc.2004.03.188
10.1016/j.ejmech.2017.08.023
10.1016/j.molcel.2016.02.011
10.2174/092986711795328382
10.15252/embr.201642455
10.1158/1078-0432.CCR-12-1557
10.1016/j.ejmech.2011.02.040
10.1016/j.bmcl.2015.11.040
10.1002/cmdc.201900541
10.1016/j.bmcl.2019.07.045
10.1515/znb-2007-0807
10.1021/acs.jmedchem.0c00305
10.1021/acs.jmedchem.0c00193
10.1021/cr100307m
10.2174/092986707781058805
10.1016/j.ejmech.2018.04.005
10.1039/c1np00051a
10.1016/j.ejmech.2013.04.023
10.1007/s10637-013-0062-5
10.1016/j.steroids.2008.12.007
10.1021/acsmedchemlett.7b00545
10.1038/nature03566
10.1021/acs.inorgchem.8b03386
10.1101/gad.287524.116
10.1016/j.ejmech.2011.03.015
10.1016/j.ejmech.2017.12.038
10.3892/ol.2016.4606
10.1039/B816679J
10.1021/acs.jmedchem.7b00663
10.1080/14756366.2017.1417274
10.1021/acs.jmedchem.0c00343
10.1016/j.memsci.2018.11.016
10.1038/nature12327
10.1016/j.ctrv.2007.08.001
10.1021/jm200570p
10.1111/j.1349-7006.2009.01195.x
10.1021/acs.molpharmaceut.8b00566
10.4155/fmc.09.80
10.2174/138955711796268750
10.18388/abp.2016_1264
10.1039/C8MD00278A
10.1016/j.bmc.2014.03.026
10.1002/ardp.19963290707
10.1016/j.ejmech.2018.02.079
10.1039/C8CC05010D
10.1038/cddis.2011.70
10.1007/s10637-019-00767-7
10.1182/blood-2013-07-516807
10.1021/acsomega.0c00630
10.1016/j.bmc.2003.11.036
10.1016/j.ejmech.2017.04.003
10.1016/j.bmc.2005.02.039
10.1023/B:BREA.0000013996.49528.d8
10.1016/j.cbi.2019.02.002
10.2174/092986732311160420104823
10.1021/acs.jmedchem.8b01610
10.1016/j.ejmech.2014.02.026
10.1016/j.biopha.2020.111044
10.1016/j.ejmech.2014.04.052
10.1021/acs.jmedchem.6b00276
10.1021/acs.jmedchem.9b00390
10.1016/S0140-6736(19)32222-6
10.1007/s10555-007-9064-0
10.1039/C7CC07622C
10.1016/j.phrs.2015.10.021
10.1016/j.ejmech.2011.09.049
10.1016/j.ejmech.2018.02.033
10.3390/molecules20022973
10.2174/1871520615666150101130209
10.1038/nrd2926
10.1016/j.ejmech.2018.11.061
10.1111/boc.201400004
10.1016/j.ejmech.2016.03.087
10.1016/j.bioorg.2019.01.026
10.1016/j.steroids.2019.108507
10.1002/med.21442
10.1016/j.bioorg.2019.103382
10.2147/DDDT.S227862
10.1016/j.ejmech.2013.01.016
10.1172/JCI69738
10.2174/0929867324666170414165253
10.1016/S0960-894X(01)00136-6
ContentType Journal Article
Copyright 2023 Wiley Periodicals LLC.
Copyright_xml – notice: 2023 Wiley Periodicals LLC.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1002/med.21963
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE
MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1098-1128
EndPage 1808
ExternalDocumentID 37183170
10_1002_med_21963
MED21963
Genre reviewArticle
Research Support, Non-U.S. Gov't
Journal Article
Review
GrantInformation_xml – fundername: National Key R&D Program of China
  funderid: 2019YFA0905700; 2021YFC2101500
– fundername: National Natural Science Foundation of China
  funderid: 21838002
– fundername: National Natural Science Foundation for Distinguished Young Scholars
  funderid: 21625602
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
GWYGA
H.X
HBH
HF~
HGLYW
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LSO
LUTES
LW6
LYRES
M6Q
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
SAMSI
SUPJJ
SV3
UB1
V8K
W8V
W99
WBFHL
WBKPD
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WWP
WXI
WXSBR
WYISQ
XG1
XV2
YCJ
ZGI
ZZTAW
~IA
~WT
AAYXX
ADXHL
AEYWJ
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
K9.
7X8
ID FETCH-LOGICAL-c3533-682663f560e9dabdeea9ac03c0a153f4543e2ce2b52484f36743def18f384e8b3
IEDL.DBID DR2
ISSN 0198-6325
1098-1128
IngestDate Thu Jul 10 22:08:39 EDT 2025
Fri Jul 25 21:20:33 EDT 2025
Thu Apr 03 07:10:08 EDT 2025
Thu Apr 24 23:08:30 EDT 2025
Tue Jul 01 02:04:06 EDT 2025
Wed Jan 22 16:17:47 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords traditional Chinese medicine
antitumor drug
drugs combination
active components
Language English
License 2023 Wiley Periodicals LLC.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3533-682663f560e9dabdeea9ac03c0a153f4543e2ce2b52484f36743def18f384e8b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0000-0002-8342-5201
PMID 37183170
PQID 2846877023
PQPubID 1016383
PageCount 31
ParticipantIDs proquest_miscellaneous_2813889743
proquest_journals_2846877023
pubmed_primary_37183170
crossref_citationtrail_10_1002_med_21963
crossref_primary_10_1002_med_21963
wiley_primary_10_1002_med_21963_MED21963
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate September 2023
2023-09-00
20230901
PublicationDateYYYYMMDD 2023-09-01
PublicationDate_xml – month: 09
  year: 2023
  text: September 2023
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Hoboken
PublicationTitle Medicinal research reviews
PublicationTitleAlternate Med Res Rev
PublicationYear 2023
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2010; 10
2010; 17
2013; 62
2013; 64
2019; 14
2019; 19
2020; 15
2016; 30
2008; 34
2011; 54
2020; 14
2020; 12
2019; 163
2014; 22
2011; 111
2018; 9
2018; 3
2019; 20
2020; 94
2007; 6
2007; 7
2019; 29
2010; 3
2004; 339
2019; 394
2018; 33
2012; 22
2014; 11
2014; 123
2014; 124
2007; 17
2017; 64
2019; 9
2015; 58
2018; 28
2017; 60
2011; 2
2011; 1
2010; 39
2013; 500
2019; 37
2018; 23
2017; 134
1996; 16
2017; 138
2012; 31
2018; 25
2016; 12
2017; 139
2010; 45
2016; 7
2009; 74
2018; 194
1995; 49
2020; 153
2019; 48
2009; 100
2022; 15
2020; 25
2017; 141
1992; 27
2004; 318
2016; 29
2018; 11
2016; 26
2018; 15
2016; 23
2005; 13
2014; 32
2019; 572
2017; 5
1990; 11
2020; 63
2013; 24
2000; 46
2016; 107
2019; 58
2018; 81
2011; 11
2022; 63
2017; 350
2016; 103
2011; 18
2013; 19
2021; 35
2021; 38
2020; 5
2009; 52
2019; 62
2021; 33
2017; 37
2016; 119
2016; 85
2011; 26
2011; 28
2001; 11
2014; 8
2005; 39
2017; 127
2007; 26
2015; 2
2021; 8
2015; 15
1996; 329
2004; 83
2015; 6
1984; 81
2017; 25
2017; 27
2019; 78
2018; 145
2005; 435
2018; 148
2019; 302
2004
2011; 39
2012; 77
2015; 7
2016; 59
2014; 87
2007; 356
2014; 106
2014; 80
2018; 151
2019; 86
2017; 14
2019; 88
2015; 20
2009; 9
2009; 8
2011; 46
2016; 61
2017; 18
2009; 1
2018; 54
2014; 76
e_1_2_8_68_1
Cordell GA (e_1_2_8_11_1) 2010; 3
e_1_2_8_132_1
e_1_2_8_155_1
Luo H (e_1_2_8_3_1) 2019; 48
e_1_2_8_151_1
e_1_2_8_9_1
e_1_2_8_117_1
e_1_2_8_22_1
e_1_2_8_45_1
e_1_2_8_64_1
e_1_2_8_87_1
e_1_2_8_113_1
e_1_2_8_136_1
e_1_2_8_159_1
e_1_2_8_41_1
e_1_2_8_60_1
e_1_2_8_83_1
e_1_2_8_19_1
Wang D (e_1_2_8_34_1) 2019; 20
e_1_2_8_109_1
e_1_2_8_15_1
e_1_2_8_38_1
e_1_2_8_57_1
Bai M (e_1_2_8_6_1) 2015; 2
e_1_2_8_120_1
e_1_2_8_143_1
e_1_2_8_91_1
e_1_2_8_95_1
Zhang HB (e_1_2_8_5_1) 2011; 26
e_1_2_8_99_1
Yang WQ (e_1_2_8_21_1) 2022; 15
e_1_2_8_105_1
e_1_2_8_128_1
Yang WQ (e_1_2_8_27_1) 2020; 15
e_1_2_8_53_1
e_1_2_8_76_1
e_1_2_8_101_1
e_1_2_8_124_1
e_1_2_8_147_1
Abe M (e_1_2_8_43_1) 2019; 9
e_1_2_8_72_1
e_1_2_8_29_1
e_1_2_8_25_1
e_1_2_8_48_1
e_1_2_8_2_1
e_1_2_8_133_1
e_1_2_8_110_1
e_1_2_8_152_1
Wang R (e_1_2_8_26_1) 2019; 88
e_1_2_8_67_1
Zhou W (e_1_2_8_69_1) 2020; 25
e_1_2_8_44_1
e_1_2_8_86_1
e_1_2_8_118_1
e_1_2_8_63_1
e_1_2_8_137_1
e_1_2_8_40_1
e_1_2_8_82_1
e_1_2_8_114_1
e_1_2_8_156_1
e_1_2_8_18_1
e_1_2_8_14_1
e_1_2_8_37_1
e_1_2_8_79_1
e_1_2_8_94_1
e_1_2_8_144_1
e_1_2_8_90_1
e_1_2_8_121_1
e_1_2_8_98_1
e_1_2_8_140_1
e_1_2_8_10_1
e_1_2_8_56_1
e_1_2_8_106_1
e_1_2_8_75_1
e_1_2_8_129_1
Coley HM (e_1_2_8_46_1) 1996; 16
e_1_2_8_52_1
e_1_2_8_102_1
e_1_2_8_148_1
e_1_2_8_71_1
e_1_2_8_125_1
e_1_2_8_28_1
e_1_2_8_47_1
Dobrusin EM (e_1_2_8_49_1) 1992
e_1_2_8_81_1
e_1_2_8_111_1
e_1_2_8_130_1
e_1_2_8_153_1
e_1_2_8_7_1
e_1_2_8_20_1
e_1_2_8_66_1
e_1_2_8_89_1
e_1_2_8_119_1
e_1_2_8_138_1
e_1_2_8_62_1
e_1_2_8_85_1
e_1_2_8_115_1
e_1_2_8_134_1
e_1_2_8_157_1
e_1_2_8_17_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_59_1
e_1_2_8_70_1
e_1_2_8_122_1
e_1_2_8_141_1
e_1_2_8_97_1
e_1_2_8_160_1
Kavak E (e_1_2_8_23_1) 2021; 8
e_1_2_8_32_1
e_1_2_8_55_1
e_1_2_8_78_1
e_1_2_8_107_1
e_1_2_8_149_1
e_1_2_8_51_1
e_1_2_8_74_1
Liu CJ (e_1_2_8_33_1) 2010; 45
e_1_2_8_103_1
e_1_2_8_126_1
e_1_2_8_145_1
e_1_2_8_93_1
e_1_2_8_80_1
e_1_2_8_154_1
e_1_2_8_4_1
e_1_2_8_131_1
e_1_2_8_150_1
Chabner BA (e_1_2_8_12_1) 1990; 11
e_1_2_8_8_1
e_1_2_8_42_1
e_1_2_8_88_1
e_1_2_8_116_1
e_1_2_8_65_1
e_1_2_8_139_1
e_1_2_8_84_1
e_1_2_8_112_1
e_1_2_8_158_1
Barret JM (e_1_2_8_30_1) 2007; 6
e_1_2_8_61_1
e_1_2_8_135_1
e_1_2_8_39_1
e_1_2_8_35_1
e_1_2_8_16_1
e_1_2_8_58_1
Xie B (e_1_2_8_24_1) 2011; 1
e_1_2_8_92_1
e_1_2_8_96_1
e_1_2_8_100_1
e_1_2_8_142_1
e_1_2_8_161_1
e_1_2_8_31_1
e_1_2_8_77_1
e_1_2_8_127_1
e_1_2_8_54_1
e_1_2_8_108_1
e_1_2_8_73_1
e_1_2_8_123_1
e_1_2_8_50_1
e_1_2_8_104_1
e_1_2_8_146_1
References_xml – volume: 8
  start-page: 495
  year: 2014
  end-page: 502
  article-title: Hybrids of the benzofuran core from natural products and the 2,4‐dihydroxy‐5‐isopropylbenzene fragment as potent Hsp90 inhibitors: design, Synthesis and Bioevaluation
  publication-title: Mol Inf
– volume: 7
  start-page: 1
  year: 2016
  end-page: 16
  article-title: Synergistic effects of Chinese herbal medicine: a comprehensive review of methodology and current research
  publication-title: Fron Pharmacol
– volume: 6
  start-page: A270
  year: 2007
  article-title: F14512, a novel targeted cytotoxic agent vectored into cells via the polyamine transport system
  publication-title: Mol Cancer Ther
– volume: 37
  start-page: 1300
  year: 2019
  end-page: 1308
  article-title: Discovery and anticancer evaluation of a formononetin derivative against gastric cancer SGC7901 cells
  publication-title: Invest New Drugs
– volume: 2
  start-page: 164
  year: 2015
  end-page: 168
  article-title: New thoughts on traditional Chinese medicine toxicity and the toxic traditional Chinese medicine
  publication-title: ICAEM
– volume: 60
  start-page: 9470
  year: 2017
  end-page: 9489
  article-title: Design of novel 3‐pyrimidinylazaindole CDK2/9 inhibitors with potent in vitro and in vivo antitumor efficacy in a triple‐negative breast cancer model
  publication-title: J Med Chem
– volume: 11
  start-page: 1
  year: 2018
  end-page: 20
  article-title: Melatonin: an anti‐tumor agent in hormone‐dependent cancers
  publication-title: Intern J Endocrinol
– volume: 39
  start-page: 105
  year: 2005
  end-page: 112
  article-title: Melatonin limits lung injury in bleomycin treated mice
  publication-title: J Pineal Res
– volume: 54
  start-page: 9031
  year: 2018
  end-page: 9034
  article-title: A highly GSH‐sensitive SN‐38 prodrug with an "OFF‐to‐ON" fluorescence switch as a bifunctional anticancer agent
  publication-title: Chem Commun
– volume: 15
  start-page: 3
  year: 2020
  article-title: Advances in pharmacological activities of terpenoids
  publication-title: Nat Proud Commun
– volume: 88
  start-page: 951
  issue: 102
  year: 2019
  article-title: Design and synthesis of the novel oleanolic acid‐cinnamic acid ester derivatives and glycyrrhetinic acid‐cinnamic acid ester derivatives with cytotoxic properties
  publication-title: Bioorg Chem
– volume: 3
  start-page: 183
  year: 2010
  end-page: 205
  article-title: The potential of alkaloids in drug discovery
  publication-title: Phyto Res
– volume: 78
  start-page: 227
  year: 2019
  end-page: 241
  article-title: Kucukguzel I. Synthesis, anticancer activity, toxicity evaluation and molecular docking studies of novel phenylaminopyrimidine‐(thio)urea hybrids as potential kinase inhibitors
  publication-title: Comput Biol Chem
– volume: 45
  start-page: 9
  year: 2010
  end-page: 16
  article-title: Bioactivity diversity and functional mechanism of tetrahydroisoquinoline alkaloids
  publication-title: Acta Pharmaceutica Sinica
– volume: 318
  start-page: 95
  year: 2004
  end-page: 102
  article-title: FAST is a BCL‐XL‐associated mitochondrial protein
  publication-title: Biochem Biophy Res Commun
– volume: 9
  start-page: 1194
  year: 2018
  end-page: 1205
  article-title: Design, synthesis and biological evaluation of benzimidazole–rhodanine conjugates as potent topoisomerase II inhibitors
  publication-title: Med Chem Comm
– volume: 83
  start-page: 195
  year: 2004
  end-page: 199
  article-title: Inhibition of breast cancer regrowth and pulmonary metastasis in nude mice by anti‐gastric ulcer agent, irsogladine
  publication-title: Breast Cancer Res Treat
– volume: 22
  start-page: 2655
  year: 2014
  end-page: 2661
  article-title: Synthesis and cellular characterization of novel isoxazolo‐ and thiazolohydrazinylidene‐chroman‐2,4‐diones on cancer and non‐cancer cell growth and death
  publication-title: Bioorg Med Chem
– volume: 63
  start-page: 186
  year: 2020
  end-page: 204
  article-title: Platinum‐based modification of styrylbenzylsulfones as multifunctional antitumor agents: targeting the RAS/RAF pathway, enhancing antitumor activity, and overcoming multidrug resistance
  publication-title: J Med Chem
– volume: 15
  start-page: 236
  year: 2015
  end-page: 246
  article-title: Anticancer activity of polyether ionophore‐salinomycin
  publication-title: Anti‐Cancer Agent Med Chem
– volume: 11
  start-page: 1251
  year: 2001
  end-page: 1255
  article-title: The synthesis of amino‐acid functionalized β‐Carbolines as topoisomerase II inhibitors
  publication-title: Bioorg Med Chem Lett
– volume: 16
  start-page: 1851
  year: 1996
  end-page: 1855
  article-title: The activity of N‐(hydroxymethyl) melamines in fresh human ovarian tumour cells and xenografts
  publication-title: Anticancer Res
– volume: 7
  start-page: 2217
  year: 2016
  end-page: 2231
  article-title: Histone deacetylase inhibitors for the treatment of cancer stem cells
  publication-title: Medchemcomm
– volume: 26
  start-page: 2931
  year: 2016
  end-page: 2935
  article-title: Targeting epigenetic reader and eraser: rational design, synthesis and in vitro evaluation of dimethylisoxazoles derivatives as BRD4/HDAC dual inhibitors
  publication-title: Bioorg Med Chem Lett
– volume: 22
  start-page: 6010
  year: 2012
  end-page: 6015
  article-title: Synthesis and evaluation of novel 2‐pyridone derivatives as inhibitors of phosphodiesterase3 (PDE3): A target for heart failure and platelet aggregation
  publication-title: Bioorg Med Chem Lett
– volume: 13
  start-page: 3853
  year: 2005
  end-page: 3864
  article-title: New antitubulin derivatives in the combretastatin A4 series: synthesis and biological evaluation
  publication-title: Bioorg Med Chem
– volume: 32
  start-page: 510
  year: 2014
  end-page: 517
  article-title: Phase I study of PF‐04691502, a small‐molecule, oral, dual inhibitor of PI3K and mTOR, in patients with advanced cancer
  publication-title: Invest New Drugs
– volume: 124
  start-page: 30
  year: 2014
  end-page: 39
  article-title: New and emerging HDAC inhibitors for cancer treatment
  publication-title: J Clin Inv
– volume: 63
  start-page: 6096
  year: 2020
  end-page: 6106
  article-title: Anticancer melatplatin prodrugs: high effect and low toxicity, MT1‐ER‐target and immune response in vivo
  publication-title: J Med Chem
– volume: 5
  start-page: 444
  year: 2017
  end-page: 454
  article-title: Rapidly cell‐penetrating and reductive milieu‐responsive nanoaggregates assembled from an amphiphilic folate‐camptothecin prodrug for enhanced drug delivery and controlled release
  publication-title: Biomaterials Sci
– volume: 435
  start-page: 519
  year: 2005
  end-page: 522
  article-title: Structural basis for the regulation of tubulin by vinblastine
  publication-title: Nature
– volume: 33
  start-page: 1516
  year: 2018
  end-page: 1528
  article-title: Benzofuran‐appended 4‐aminoquinazoline hybrids as epidermal growth factor receptor tyrosine kinase inhibitors: synthesis, biological evaluation and molecular docking studies
  publication-title: J Enzyme Inhib Med Chem
– volume: 58
  start-page: 2191
  year: 2019
  end-page: 2200
  article-title: Construction of dual stimuli‐responsive platinum(IV) hybrids with NQO1 targeting ability and overcoming cisplatin resistance
  publication-title: Inorgan Chem
– volume: 302
  start-page: 164
  year: 2019
  end-page: 171
  article-title: Effects of new tetrahydroquinoline‐isoxazole hybrids on bioenergetics of hepatocarcinoma HepG2 cells and rat liver mitochondria
  publication-title: Chem‐Biolog Inter
– volume: 8
  start-page: 627
  year: 2009
  end-page: 644
  article-title: Targeting the phosphoinositide 3‐kinase pathway in cancer
  publication-title: Nat Rev Drug Discov
– start-page: 1585
  year: 2004
  end-page: 1604
  article-title: Camptothecin: current perspectives
  publication-title: Bioorg Med Chem
– volume: 61
  start-page: 667
  year: 2016
  end-page: 676
  article-title: Mitochondria and Cancer
  publication-title: Mol Cell
– volume: 23
  start-page: 1616
  year: 2018
  article-title: Balewski Ł. Hybrid molecules composed of 2,4‐diamino‐1,3,5‐triazines and 2‐imino‐coumarins and coumarins. Synthesis and Cytotoxic Properties
  publication-title: Molecules
– volume: 28
  start-page: 1357
  year: 2018
  end-page: 1362
  article-title: Design and synthesis of triple inhibitors of janus kinase (JAK), histone deacetylase (HDAC) and Heat Shock Protein 90 (HSP90)
  publication-title: Bioorg Med Chem Lett
– volume: 19
  start-page: 4392
  year: 2013
  end-page: 4403
  article-title: Acquired resistance to anti‐VEGF therapy in glioblastoma Is associated with a mesenchymal transition
  publication-title: Clin Cancer Res
– volume: 10
  start-page: 370
  year: 2010
  article-title: Chloroquine potentiates the anti‐cancer effect of 5‐fluorouracil on colon cancer cells
  publication-title: BMC Cancer
– volume: 39
  start-page: 435
  year: 2010
  end-page: 454
  article-title: Artemisinin and its derivatives: a novel class of anti‐malarial and anti‐cancer agents
  publication-title: Chem Soc Rev
– volume: 18
  start-page: 420
  year: 2017
  end-page: 436
  article-title: MARK4 inhibits hippo signaling to promote proliferation and migration of breast cancer cells
  publication-title: EMBO Rep
– volume: 81
  start-page: 703
  year: 2018
  end-page: 721
  article-title: Quest for efficacious next‐generation taxoid anticancer agents and their tumor‐targeted delivery
  publication-title: J Nat Prod
– volume: 87
  start-page: 150
  year: 2014
  end-page: 158
  article-title: Design, regioselective synthesis and cytotoxic evaluation of 2‐aminoimidazole‐quinoline hybrids against cancer and primary endothelial cells
  publication-title: Eur J Med Chem
– volume: 85
  start-page: 287
  year: 2016
  end-page: 299
  article-title: Regiospecific synthesis, anti‐inflammatory and anticancer evaluation of novel 3,5‐disubstituted isoxazoles from the natural maslinic and oleanolic acids
  publication-title: Ind Crop Prod
– volume: 54
  start-page: 6254
  year: 2011
  end-page: 6276
  article-title: Discovery of a clinical stage multi‐kinase inhibitor sodium (E)‐2‐{2‐methoxy‐5‐(2',4',6'‐trimethoxystyrylsulfonyl)methylphenylamino}acetate (ON 01910.Na): synthesis, structure‐activity relationship, and biological activity
  publication-title: J Med Chem
– volume: 123
  start-page: 3622
  year: 2014
  end-page: 3634
  article-title: The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cells
  publication-title: Blood
– volume: 25
  start-page: 3180
  year: 2020
  article-title: Design, synthesis and anti‐tumor activity of novel benzimidazole‐chalcone hybrids as non‐intercalative topoisomerase II catalytic inhibitors
  publication-title: Biochem Pharmacol
– volume: 100
  start-page: 1366
  year: 2009
  end-page: 1373
  article-title: Significance of nitroimidazole compounds and hypoxia‐inducible factor‐1 for imaging tumor hypoxia
  publication-title: Cancer Sci
– volume: 59
  start-page: 3549
  year: 2016
  end-page: 3561
  article-title: Synthesis of α,β‐unsaturated carbonyl‐based compounds, oxime and oxime ether analogs as potential anticancer agents for overcoming cancer multidrug resistance by modulation of efflux pumps in tumor cells
  publication-title: J Med Chem
– volume: 350
  year: 2017
  article-title: Design, synthesis, and biological evaluation of coumarin‐triazole hybrid molecules as potential antitumor and pancreatic lipase agents
  publication-title: Arch Pharm
– volume: 1
  start-page: 1143
  year: 2009
  end-page: 1151
  article-title: Thiosemicarbazones: the new wave in cancer treatment
  publication-title: Future Med Chem
– volume: 103
  start-page: 26
  year: 2016
  end-page: 48
  article-title: Classification of small molecule protein kinase inhibitors based upon the structures of their drug‐enzyme complexes
  publication-title: Pharmacol Res
– volume: 19
  start-page: 1694
  year: 2019
  end-page: 1711
  article-title: Molecular hybridization as a tool for designing multitarget drug candidates for complex diseases
  publication-title: Curr Top Med Chem
– volume: 94
  year: 2020
  article-title: In‐vitro Anti‐cancer assay and apoptotic cell pathway of newly synthesized benzoxazole‐N‐heterocyclic hybrids as potent tyrosine kinase inhibitors
  publication-title: Bioorg Chem
– volume: 3
  start-page: 1955
  year: 2018
  end-page: 1969
  article-title: Drug‐clinical agent molecular hybrid: synthesis of diaryl(trifluoromethyl)pyrazoles as tubulin targeting anticancer Aagents
  publication-title: ACS Omega
– volume: 63
  start-page: 5421
  year: 2020
  end-page: 5441
  article-title: Design, synthesis, and biological evaluation of HSP90 inhibitor‐SN38 conjugates for targeted drug accumulation
  publication-title: J Med Chem
– volume: 9
  start-page: 870
  year: 2019
  end-page: 877
  article-title: The polycythemia vera‐associated Jak2 V617F mutant induces tumorigenesis in nude mice
  publication-title: Inter Immun
– volume: 52
  start-page: 4073
  year: 2009
  end-page: 4086
  article-title: The pKBHX database: toward a better understanding of hydrogen‐bond basicity for medicinal chemists
  publication-title: J Med Chem
– volume: 27
  start-page: 1624
  year: 2017
  end-page: 1626
  article-title: Synthesis and biological activity of salinomycin‐hydroxamic acid conjugates
  publication-title: Bioorg Med Chem Lett
– volume: 14
  start-page: 1829
  year: 2017
  end-page: 1852
  article-title: Molecular hybridization: a useful tool in the design of new drug prototypes
  publication-title: Curr Med Chem
– volume: 62
  start-page: 705
  year: 2013
  end-page: 721
  article-title: Synthesis and biochemical activities of antiproliferative amino acid and phosphate derivatives of microtubule‐disrupting β‐lactam combretastatins
  publication-title: Eur J Med Chem
– volume: 62
  start-page: 6992
  year: 2019
  end-page: 7014
  article-title: Design, synthesis, and biological evaluation of 4‐methyl quinazoline derivatives as anticancer agents simultaneously targeting phosphoinositide 3‐kinases and histone deacetylases
  publication-title: J Med Chem
– volume: 119
  start-page: 141
  year: 2016
  end-page: 168
  article-title: Recent developments of C‐4 substituted coumarin derivatives as anticancer agents
  publication-title: Europ J Med Chem
– volume: 62
  start-page: 4265
  year: 2019
  end-page: 4311
  article-title: A survey of the structures of US FDA approved combination drugs
  publication-title: J Med Chem
– volume: 138
  start-page: 1076
  year: 2017
  end-page: 1088
  article-title: Discovery of 5,6‐diaryl‐1,2,4‐triazines hybrids as potential apoptosis inducers
  publication-title: Eur J Med Chem
– volume: 2
  start-page: 80
  year: 2011
  end-page: 93
  article-title: Tyrosine kinase inhibitors: multi‐targeted or single‐targeted?
  publication-title: World J Clin Oncol
– volume: 15
  start-page: 3
  year: 2022
  article-title: Advances in pharmacological activities of terpenoids
  publication-title: Nat Proud Commun
– volume: 107
  start-page: 249
  year: 2016
  end-page: 275
  article-title: Cyclin‐dependent protein kinase inhibitors including palbociclib as anticancer drugs
  publication-title: Pharmacol Res
– volume: 11
  start-page: 74
  year: 1990
  end-page: 81
  article-title: Plant alkaloids
  publication-title: Cancer Chemother Biol Response Modif
– volume: 49
  start-page: 932
  issue: 6
  year: 1995
  end-page: 953
  article-title: Faulds, altretamine
  publication-title: Drugs
– volume: 111
  start-page: 7157
  year: 2011
  end-page: 7259
  article-title: Advances in the chemistry of tetrahydroquinolines
  publication-title: Chem Rev
– volume: 14
  start-page: 483
  year: 2020
  end-page: 495
  article-title: New isatin‐indole conjugates: synthesis, characterization, and a plausible mechanism of their in vitro antiproliferative activity
  publication-title: Drug Des Devel Ther
– volume: 62
  start-page: 993
  year: 2019
  end-page: 1013
  article-title: Discovery of novel quinoline‐chalcone derivatives as potent antitumor agents with microtubule polymerization inhibitory activity
  publication-title: J Med Chem
– volume: 58
  start-page: 640
  year: 2015
  end-page: 650
  article-title: Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties
  publication-title: J Med Chem
– volume: 18
  start-page: 1488
  year: 2011
  end-page: 1508
  article-title: Quinoline as a privileged scaffold in cancer drug discovery
  publication-title: Curr Med Chem
– volume: 7
  start-page: 1186
  year: 2007
  end-page: 1205
  article-title: Combretastatin a‐4 analogs as anticancer agents
  publication-title: Mini‐Rev Med Chem
– volume: 33
  year: 2021
  article-title: Anticancer activities of TCM and their active components against tumor metastasis
  publication-title: Biomed Pharmacother
– volume: 6
  start-page: 89
  year: 2015
  end-page: 94
  article-title: Distinct binding mode of multikinase inhibitor lenvatinib revealed by biochemical characterization
  publication-title: ACS Med Chem Lett
– volume: 31
  start-page: 1869
  year: 2012
  end-page: 1883
  article-title: Molecular mechanisms of cisplatin resistance
  publication-title: Oncogene
– volume: 5
  start-page: 22759
  year: 2020
  end-page: 22771
  article-title: Design and Development of small‐molecule arylaldoxime/5‐nitroimidazole hybrids as potent inhibitors of MARK4: a promising approach for target‐based vancer therapy
  publication-title: ACS Omega
– volume: 34
  start-page: 81
  year: 2008
  end-page: 91
  article-title: Novel cytotoxic drugs: old challenges, new solutions
  publication-title: Cancer Treat Rev
– volume: 29
  start-page: 311
  year: 2016
  end-page: 323
  article-title: HDAC and PI3K antagonists cooperate to inhibit growth of MYC‐driven medulloblastoma
  publication-title: Cancer Cell
– volume: 52
  start-page: 4838
  year: 2009
  end-page: 4843
  article-title: Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin
  publication-title: J Med Chem
– volume: 5
  start-page: 10089
  year: 2020
  end-page: 10098
  article-title: Molecular Hybrids integrated with benzimidazole and pyrazole structural motifs: design, synthesis, biological evaluation, and molecular docking studies
  publication-title: ACS Omega
– volume: 2
  year: 2011
  article-title: Mechanism of cell death resulting from DNA interstrand cross‐linking in mammalian cells
  publication-title: Cell Death Dis
– volume: 30
  start-page: 1913
  year: 2016
  end-page: 1930
  article-title: Recent insights into the function of autophagy in cancer
  publication-title: Genes Dev
– volume: 15
  start-page: 4173
  year: 2018
  end-page: 4189
  article-title: Thienopyrimidine–chalcone hybrid molecules inhibit fas‐activated serine/threonine kinase: an approach to ameliorate antiproliferation in human breast cancer cells
  publication-title: Mol Pharm
– volume: 106
  start-page: 294
  year: 2014
  end-page: 307
  article-title: Mark4 promotes adipogenesis and triggers apoptosis in 3T3‐L1 adipocytes by activating JNK1 and inhibiting p38MAPK pathways
  publication-title: Biol Cell
– volume: 500
  start-page: 486
  year: 2013
  end-page: 489
  article-title: Structural basis for molecular recognition of folic acid by folate receptors
  publication-title: Nature
– volume: 17
  start-page: 4270
  year: 2010
  end-page: 4290
  article-title: Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs
  publication-title: Curr Med Chem
– volume: 18
  start-page: 610
  year: 2017
  end-page: 621
  article-title: The multifaceted roles of PARP1 in DNA repair and chromatin remodelling
  publication-title: Nat Rev Mol Cell Biol
– volume: 20
  start-page: 2973
  year: 2015
  end-page: 3000
  article-title: Indole alkaloids from catharanthus roseus: bioproduction and their effect on human health
  publication-title: Molecules
– volume: 356
  start-page: 115
  year: 2007
  end-page: 124
  article-title: Sunitinib versus interferon alfa in metastatic renal‐cell carcinoma
  publication-title: New Eng J Med
– volume: 86
  start-page: 80
  year: 2019
  end-page: 96
  article-title: New thiazol‐hydrazono‐coumarin hybrids targeting human cervical cancer cells: Synthesis, CDK2 inhibition, QSAR and molecular docking studies
  publication-title: Bioorg Chem
– volume: 76
  start-page: 539
  year: 2014
  end-page: 548
  article-title: Anticancer activity of new coumarin substituted hydrazide‐hydrazone derivatives
  publication-title: Europ J Med Chem
– volume: 24
  start-page: 14
  year: 2013
  end-page: 19
  article-title: Chloroquine overcomes resistance of lung carcinoma cells to the dual PI3K/mTOR inhibitor PI103 by lysosome‐mediated apoptosis
  publication-title: Anti‐Cancer Drugs
– volume: 7
  start-page: 127
  year: 2015
  article-title: Epigenetic treatment of solid tumours: a review of clinical trials
  publication-title: Clin Epigenet
– volume: 27
  start-page: 169
  year: 1992
  end-page: 178
– volume: 46
  start-page: 5868
  year: 2011
  end-page: 5877
  article-title: Synthesis and cytotoxic activity of novel 3‐(1H‐indol‐3‐yl)‐1H‐pyrazole‐5‐carbohydrazide derivatives
  publication-title: Eur J Med Chem
– volume: 63
  start-page: 151
  year: 2022
  end-page: 163
  article-title: Drug combination modeling: methods and applications in drug development
  publication-title: J Clin Pharm
– volume: 8
  start-page: 1
  year: 2021
  end-page: 9
  article-title: Design, synthesis and pharmacological evaluation of novel artemisinin‐thymol
  publication-title: Nat Prod Res
– volume: 63
  start-page: 3028
  year: 2020
  end-page: 3046
  article-title: Design, synthesis, and biological evaluation of imidazo 1,2‐a pyridine derivatives as novel PI3K/mTOR dual inhibitors
  publication-title: J Med Chem
– volume: 127
  start-page: 928
  year: 2017
  end-page: 943
  article-title: Design, facile synthesis and biological evaluations of novel pyrano[3,2‐a]phenazine hybrid molecules as antitumor agents
  publication-title: Europ J Med Chem
– volume: 153
  start-page: 23
  year: 2020
  article-title: Pharmacological activities of dehydroepiandrosterone: a review
  publication-title: Steroids
– volume: 15
  start-page: 273
  year: 2018
  end-page: 291
  article-title: Targeting the PI3K pathway in cancer: are we making headway?
  publication-title: Nat Rev Clin Oncol
– volume: 37
  start-page: 1461
  year: 2017
  end-page: 1491
  article-title: Therapeutic targeting of poly(ADP‐Ribose) polymerase‐1 (PARP1) in cancer: current developments, therapeutic strategies, and future opportunities
  publication-title: Med Res Rev
– volume: 329
  start-page: 371
  year: 1996
  end-page: 376
  article-title: Phenylamino‐pyrimidine (PAP) derivatives: a new class of potent and selective inhibitors of protein kinase C (PKC)
  publication-title: Archiv Der Pharmazie
– volume: 6
  start-page: 1045
  year: 2007
  end-page: 1051
  article-title: Synthesis of some ethyl 3‐(Aryldiazenyl)‐7‐oxo‐dihydropyrido[2,3‐f]quinoxaline‐8‐carboxylates
  publication-title: Z Naturforsh B
– volume: 151
  start-page: 214
  year: 2018
  end-page: 225
  article-title: Synthesis and anticancer activity evaluation of novel azacalix[2]arene[2]pyrimidines
  publication-title: Eur J Med Chem
– volume: 134
  start-page: 159
  year: 2017
  end-page: 184
  article-title: Indoles as therapeutics of interest in medicinal chemistry: bird's eye view
  publication-title: Eur J Med Chem
– volume: 80
  start-page: 184
  year: 2014
  end-page: 191
  article-title: Synthesis of novel 1,2,3‐triazole substituted‐N‐alkyl/aryl nitrone derivatives, their anti‐inflammatory and anticancer activity
  publication-title: Europ J Med Chem
– volume: 35
  start-page: 5752
  year: 2021
  end-page: 5756
  article-title: Synthesis and biological evaluation of camptothecin substituted norcantharimide derivative
  publication-title: Nat Prod Res
– volume: 9
  start-page: 397
  year: 2009
  end-page: 414
  article-title: Cytotoxic and Anticancer Activities of Isatin and Its Derivatives: A Comprehensive Review from 2000‐2008
  publication-title: Anti‐Cancer Agents Med Chem
– volume: 17
  start-page: 2150
  year: 2007
  end-page: 2155
  article-title: The synthesis and biological evaluation of novel series of nitrile‐containing fluoroquinolones as antibacterial agents
  publication-title: Bioorg Med Chem Lett
– volume: 339
  start-page: 773
  year: 2004
  end-page: 784
  article-title: Mechanisms of camptothecin resistance by human topoisomerase I mutations
  publication-title: J Mol Biol
– volume: 81
  start-page: 4090
  year: 1984
  article-title: Relationships between the structures of taxol and baccatine III derivatives and their in vitro action on the disassembly of mammalian brain and Physarum amoebal microtubules
  publication-title: Proc Nat Acad Sci
– volume: 139
  start-page: 961
  year: 2017
  end-page: 981
  article-title: Acridone‐pyrimidine hybrids‐design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies
  publication-title: Eur J Med Chem
– volume: 48
  start-page: 1
  year: 2019
  end-page: 58
  article-title: Naturally occurring anti‐cancer compounds: shining from Chinese herbal medicine
  publication-title: Chin Med
– volume: 46
  start-page: 1813
  year: 2011
  end-page: 1820
  article-title: Applications of 2‐arylhydrazononitriles in synthesis: Preparation of new indole containing 1,2,3‐triazole, pyrazole and pyrazolo 1,5‐a pyrimidine derivatives and evaluation of their antimicrobial activities
  publication-title: Europ J Med Chem
– volume: 26
  start-page: 762
  year: 2011
  end-page: 765
  article-title: Advances in fresh Chinese medicine research
  publication-title: Chin J Tradit Chin Med Pharm
– volume: 74
  start-page: 424
  year: 2009
  end-page: 434
  article-title: Structural analysis and antitussive evaluation of five novel esters of verticinone and bile acids
  publication-title: Steroids
– volume: 163
  start-page: 37
  year: 2019
  end-page: 53
  article-title: Type IIA ‐ Type IIB protein tyrosine kinase inhibitors hybridization as an efficient approach for potent multikinase inhibitor development: design, synthesis, anti‐proliferative activity, multikinase inhibitory activity and molecular modeling of novel indolinone‐based ureides and amides
  publication-title: Eur J Med Chem
– volume: 9
  start-page: 283
  year: 2018
  end-page: 288
  article-title: Synthesis and biological screening of pyrano[3,2‐c]quinoline analogues as anti‐inflammatory and anticancer agents
– volume: 25
  start-page: 2034
  year: 2018
  end-page: 2044
  article-title: Overview of cantharidin and its analogues
  publication-title: Curr Med Chem
– volume: 14
  start-page: 2052
  year: 2019
  end-page: 2060
  article-title: Synthesis of combretastatin‐A4 carboxamidest that mimic sulfonyl piperazines by a molecular hybridization approach: in vitro cytotoxicity evaluation and inhibition of tubulin polymerization
  publication-title: Chem Med Chem
– volume: 33
  start-page: 714
  year: 2018
  end-page: 721
  article-title: Zinc binding groups for histone deacetylase inhibitors
  publication-title: J Enzyme Inhib Med Chem
– volume: 23
  start-page: 1100
  year: 2016
  end-page: 1130
  article-title: Pyridine based antitumour compounds acting at the colchicine site
  publication-title: Curr Med Chem
– volume: 12
  year: 2020
  article-title: New anti‐cancer strategy to suppress colorectal cancer growth through inhibition of atg4b and lysosome function
  publication-title: Cancers
– volume: 46
  start-page: 101
  year: 2000
  end-page: 113
  article-title: F11782, a dual inhibitor of topoisomerases I and II with an original mechanism of action in vitro, and markedly superior in vivo antitumour activity, relative to three other dual topoisomerase inhibitors, intoplicin, aclarubicin and TAS‐103
  publication-title: Cancer Chemother Pharmacol
– volume: 194
  start-page: 21
  year: 2018
  end-page: 35
  article-title: Design, synthesis, biological assessment and molecular docking studies of new 2‐aminoimidazole‐quinoxaline hybrids as potential anticancer agents
  publication-title: Spectrochim Acta A Mol Biomol
– volume: 11
  start-page: 695
  year: 2011
  end-page: 713
  article-title: Caffeic acid, a versatile pharmacophore: an overview
  publication-title: Mini‐Rev Med Chem
– volume: 77
  start-page: 10
  year: 2012
  end-page: 15
  article-title: Oleanolic acid
  publication-title: Phytochemistry
– volume: 20
  start-page: 17
  year: 2019
  article-title: Synthesis of N‐hydroxycinnamoyl amide derivatives and evaluation of their anti‐oxidative and anti‐tyrosinase activities
  publication-title: Bioorg Med Chem
– volume: 29
  start-page: 2638
  year: 2019
  end-page: 2645
  article-title: Anti‐tumor activity evaluation of novel tubulin and HDAC dual‐targeting inhibitors
  publication-title: Bioorg Med Chem Lett
– volume: 39
  start-page: 192
  year: 2011
  end-page: 210
  article-title: Protein kinase inhibitors drug discovery
  publication-title: Bioorg Chem
– volume: 64
  start-page: 389
  year: 2013
  end-page: 395
  article-title: Synthesis and evaluation of antimicrobial activity of hydrazones derived from 3‐oxido‐1H‐imidazole‐4‐carbohydrazides
  publication-title: Eur J Med Chem
– volume: 394
  start-page: 1929
  year: 2019
  end-page: 1939
  article-title: Durvalumab plus platinum–etoposide versus platinum–etoposide in first‐line treatment of extensive‐stage small‐cell lung cancer (CASPIAN): a randomised, controlled, open‐label, phase 3 trial
  publication-title: Lancet
– volume: 11
  start-page: 2431
  year: 2014
  end-page: 2441
  article-title: Pyrimidine‐based compounds modulate CXCR2‐mediated signaling and receptor turnover
  publication-title: Mol Pharm
– volume: 12
  start-page: 63
  year: 2016
  end-page: 68
  article-title: Gefitinib induces lung cancer cell autophagy and apoptosis via blockade of the PI3K/AKT/mTOR pathway
  publication-title: Oncol Lett
– volume: 151
  start-page: 434
  year: 2018
  end-page: 449
  article-title: Design, synthesis, cytotoxicity and mechanism of novel dihydroartemisinin‐coumarin hybrids as potential anti‐cancer agents
  publication-title: Eur J Med Chem
– volume: 1
  start-page: 62
  year: 2011
  end-page: 65
  article-title: Dihydroartemisinin mononitrate isosorbide synthesis and in vitro anti‐tumor activity of ester conjugates
  publication-title: Synth Chem
– volume: 46
  start-page: 2327
  year: 2011
  end-page: 2346
  article-title: Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: Search for anticancer agent
  publication-title: Eur J Med Chem
– volume: 38
  start-page: 470
  year: 2021
  end-page: 488
  article-title: Challenges and potential on improving druggability of podophyllotoxin‐derived drugs in cancer chemotherapy
  publication-title: Nat Prod Rep
– volume: 26
  start-page: 677
  year: 2016
  end-page: 683
  article-title: Design, synthesis and biological evaluation of pyrazolyl‐nitroimidazole derivatives as potential EGFR/HER‐2 kinase inhibitors
  publication-title: Bioorga Med Chem Lett
– volume: 62
  start-page: 3051
  year: 2019
  end-page: 3067
  article-title: Discovery of Novel bromophenol–thiosemicarbazone hybrids as potent selective inhibitors of poly(ADP‐ribose) polymerase‐1 (PARP‐1) for use in cancer
  publication-title: J Med Chem
– volume: 141
  start-page: 211
  year: 2017
  end-page: 220
  article-title: Platinum(IV) prodrugs multiply targeting genomic DNA, histone deacetylases and PARP‐1
  publication-title: Europ J Med Chem
– volume: 25
  start-page: 1066
  year: 2017
  end-page: 1075
  article-title: Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action
  publication-title: Bioorg Med Chem
– volume: 64
  start-page: 41
  year: 2017
  end-page: 48
  article-title: Anticancer activity of new molecular hybrids combining 1,4‐naphthalenedione motif with phosphonic acid moiety in hepatocellular carcinoma HepG2 cells
  publication-title: Acta Biochim Pol
– volume: 54
  start-page: 731
  year: 2018
  end-page: 734
  article-title: Coordination‐driven self‐assembly of a Pt(IV) prodrug‐conjugated supramolecular hexagon
  publication-title: Chem Commun
– volume: 148
  start-page: 359
  year: 2018
  end-page: 371
  article-title: Potent hydrazone derivatives targeting esophageal cancer cells
  publication-title: Europ J Med Chem
– volume: 572
  start-page: 428
  year: 2019
  end-page: 441
  article-title: A novel ion‐imprinted membrane induced by amphiphilic block copolymer for selective separation of Pt(IV) from aqueous solutions
  publication-title: J Memb Sci
– volume: 5
  start-page: 5589
  year: 2020
  end-page: 5600
  article-title: Palladium‐catalyzed synthesis and anticancer activity of paclitaxel–dehydroepiandrosterone hybrids
  publication-title: ACS Omega
– volume: 145
  start-page: 35
  year: 2018
  end-page: 40
  article-title: Design, synthesis and biological evaluations of novel pyridone‐thiazole hybrid molecules as antitumor agents
  publication-title: Eur J Med Chem
– volume: 127
  start-page: 235
  year: 2017
  end-page: 249
  article-title: Novel indolizino[8,7‐b]indole hybrids as anti‐small cell lung cancer agents: Regioselective modulation of topoisomerase II inhibitory and DNA crosslinking activities
  publication-title: Eur J Med Chem
– volume: 26
  start-page: 299
  year: 2007
  end-page: 310
  article-title: Regulation of tumor pH and the role of carbonic anhydrase 9
  publication-title: Cancer Metast Rev
– volume: 28
  start-page: 1937
  year: 2011
  end-page: 1955
  article-title: Multitargeting by curcumin as revealed by molecular interaction studies
  publication-title: Nat Prod Rep
– volume: 63
  start-page: 4256
  year: 2020
  end-page: 4292
  article-title: Design, synthesis, and biological evaluation of quinazolin‐4‐one‐based hydroxamic acids as dual PI3K/HDAC inhibitors
  publication-title: J Med Chem
– ident: e_1_2_8_108_1
  doi: 10.1016/j.ccell.2016.02.011
– ident: e_1_2_8_80_1
  doi: 10.1021/acs.jmedchem.8b01946
– ident: e_1_2_8_55_1
  doi: 10.1016/j.bmcl.2017.01.080
– ident: e_1_2_8_58_1
  doi: 10.1021/ml500394m
– ident: e_1_2_8_2_1
  doi: 10.3389/fphar.2016.00201
– ident: e_1_2_8_51_1
  doi: 10.1080/14756366.2018.1510919
– volume: 6
  start-page: A270
  year: 2007
  ident: e_1_2_8_30_1
  article-title: F14512, a novel targeted cytotoxic agent vectored into cells via the polyamine transport system
  publication-title: Mol Cancer Ther
– ident: e_1_2_8_127_1
  doi: 10.1038/onc.2011.384
– ident: e_1_2_8_136_1
  doi: 10.1056/NEJMoa065044
– ident: e_1_2_8_76_1
  doi: 10.1038/nrm.2017.53
– ident: e_1_2_8_89_1
  doi: 10.1186/1471-2407-10-370
– ident: e_1_2_8_152_1
  doi: 10.1016/j.bmcl.2012.05.019
– ident: e_1_2_8_63_1
  doi: 10.1021/acs.jmedchem.8b01755
– ident: e_1_2_8_135_1
  doi: 10.2174/1871520610909040397
– ident: e_1_2_8_45_1
  doi: 10.2165/00003495-199549060-00007
– ident: e_1_2_8_84_1
  doi: 10.1021/acsomega.0c00558
– ident: e_1_2_8_106_1
  doi: 10.1038/nrclinonc.2018.28
– ident: e_1_2_8_93_1
  doi: 10.1016/j.ejmech.2017.07.011
– ident: e_1_2_8_57_1
  doi: 10.1016/j.phrs.2016.03.012
– ident: e_1_2_8_81_1
  doi: 10.1021/acs.jnatprod.7b01012
– ident: e_1_2_8_72_1
  doi: 10.1021/mp500180e
– ident: e_1_2_8_78_1
  doi: 10.1021/jm501573b
– ident: e_1_2_8_85_1
  doi: 10.1016/j.bmcl.2007.01.090
– ident: e_1_2_8_9_1
  doi: 10.1002/jcph.2128
– ident: e_1_2_8_160_1
  doi: 10.1016/j.ejmech.2016.10.068
– ident: e_1_2_8_131_1
  doi: 10.1016/j.bioorg.2011.07.004
– ident: e_1_2_8_16_1
  doi: 10.1021/jm900610k
– ident: e_1_2_8_31_1
  doi: 10.1007/s002800000133
– ident: e_1_2_8_25_1
  doi: 10.1016/j.phytochem.2011.12.022
– ident: e_1_2_8_35_1
  doi: 10.1002/minf.201300182
– ident: e_1_2_8_59_1
  doi: 10.1016/j.compbiolchem.2018.12.003
– ident: e_1_2_8_44_1
  doi: 10.1016/j.bmc.2016.12.019
– ident: e_1_2_8_90_1
  doi: 10.1097/CAD.0b013e32835a36db
– ident: e_1_2_8_102_1
  doi: 10.1016/j.indcrop.2016.03.024
– ident: e_1_2_8_154_1
  doi: 10.1016/j.ejmech.2016.12.046
– ident: e_1_2_8_64_1
  doi: 10.2174/138955707782795647
– ident: e_1_2_8_128_1
  doi: 10.1016/j.ejmech.2017.09.074
– volume: 20
  start-page: 17
  year: 2019
  ident: e_1_2_8_34_1
  article-title: Synthesis of N‐hydroxycinnamoyl amide derivatives and evaluation of their anti‐oxidative and anti‐tyrosinase activities
  publication-title: Bioorg Med Chem
– ident: e_1_2_8_149_1
  doi: 10.1016/j.ejmech.2014.09.055
– ident: e_1_2_8_10_1
  doi: 10.2174/1568026619666190619115735
– ident: e_1_2_8_42_1
  doi: 10.1002/ardp.201600369
– ident: e_1_2_8_67_1
  doi: 10.1021/acsomega.7b01784
– volume: 11
  start-page: 74
  year: 1990
  ident: e_1_2_8_12_1
  article-title: Plant alkaloids
  publication-title: Cancer Chemother Biol Response Modif
– ident: e_1_2_8_54_1
  doi: 10.1039/C6MD00297H
– ident: e_1_2_8_159_1
  doi: 10.2174/092986710793361252
– ident: e_1_2_8_117_1
  doi: 10.1155/2018/3271948
– ident: e_1_2_8_86_1
  doi: 10.1021/jm801331y
– ident: e_1_2_8_116_1
  doi: 10.1111/j.1600-079X.2005.00229.x
– ident: e_1_2_8_82_1
  doi: 10.1073/pnas.81.13.4090
– ident: e_1_2_8_92_1
  doi: 10.3390/cancers12061523
– ident: e_1_2_8_119_1
  doi: 10.1039/C6BM00800C
– ident: e_1_2_8_132_1
  doi: 10.5306/wjco.v2.i2.80
– ident: e_1_2_8_14_1
  doi: 10.1016/j.jmb.2004.03.077
– ident: e_1_2_8_48_1
  doi: 10.3390/molecules23071616
– ident: e_1_2_8_121_1
  doi: 10.1016/j.bmcl.2018.03.009
– ident: e_1_2_8_151_1
  doi: 10.1016/j.saa.2017.12.063
– ident: e_1_2_8_126_1
  doi: 10.1021/acs.jmedchem.9b01223
– volume: 15
  start-page: 3
  year: 2020
  ident: e_1_2_8_27_1
  article-title: Advances in pharmacological activities of terpenoids
  publication-title: Nat Proud Commun
– ident: e_1_2_8_100_1
  doi: 10.1016/j.bmcl.2016.04.034
– volume: 26
  start-page: 762
  year: 2011
  ident: e_1_2_8_5_1
  article-title: Advances in fresh Chinese medicine research
  publication-title: Chin J Tradit Chin Med Pharm
– ident: e_1_2_8_28_1
  doi: 10.1039/D0NP00041H
– ident: e_1_2_8_109_1
  doi: 10.1186/s13148-015-0157-2
– ident: e_1_2_8_124_1
  doi: 10.1021/acs.jmedchem.9b01736
– ident: e_1_2_8_17_1
  doi: 10.1080/14786419.2020.1834546
– volume: 15
  start-page: 3
  year: 2022
  ident: e_1_2_8_21_1
  article-title: Advances in pharmacological activities of terpenoids
  publication-title: Nat Proud Commun
– volume: 9
  start-page: 870
  year: 2019
  ident: e_1_2_8_43_1
  article-title: The polycythemia vera‐associated Jak2 V617F mutant induces tumorigenesis in nude mice
  publication-title: Inter Immun
– ident: e_1_2_8_147_1
  doi: 10.1021/acsomega.0c01703
– ident: e_1_2_8_70_1
  doi: 10.1016/j.bbrc.2004.03.188
– ident: e_1_2_8_130_1
  doi: 10.1016/j.ejmech.2017.08.023
– volume: 45
  start-page: 9
  year: 2010
  ident: e_1_2_8_33_1
  article-title: Bioactivity diversity and functional mechanism of tetrahydroisoquinoline alkaloids
  publication-title: Acta Pharmaceutica Sinica
– ident: e_1_2_8_103_1
  doi: 10.1016/j.molcel.2016.02.011
– ident: e_1_2_8_61_1
  doi: 10.2174/092986711795328382
– ident: e_1_2_8_142_1
  doi: 10.15252/embr.201642455
– ident: e_1_2_8_158_1
  doi: 10.1158/1078-0432.CCR-12-1557
– ident: e_1_2_8_40_1
  doi: 10.1016/j.ejmech.2011.02.040
– ident: e_1_2_8_145_1
  doi: 10.1016/j.bmcl.2015.11.040
– ident: e_1_2_8_66_1
  doi: 10.1002/cmdc.201900541
– ident: e_1_2_8_113_1
  doi: 10.1016/j.bmcl.2019.07.045
– ident: e_1_2_8_150_1
  doi: 10.1515/znb-2007-0807
– ident: e_1_2_8_122_1
  doi: 10.1021/acs.jmedchem.0c00305
– ident: e_1_2_8_112_1
  doi: 10.1021/acs.jmedchem.0c00193
– ident: e_1_2_8_101_1
  doi: 10.1021/cr100307m
– ident: e_1_2_8_8_1
  doi: 10.2174/092986707781058805
– volume: 2
  start-page: 164
  year: 2015
  ident: e_1_2_8_6_1
  article-title: New thoughts on traditional Chinese medicine toxicity and the toxic traditional Chinese medicine
  publication-title: ICAEM
– ident: e_1_2_8_96_1
  doi: 10.1016/j.ejmech.2018.04.005
– volume: 8
  start-page: 1
  year: 2021
  ident: e_1_2_8_23_1
  article-title: Design, synthesis and pharmacological evaluation of novel artemisinin‐thymol
  publication-title: Nat Prod Res
– ident: e_1_2_8_37_1
  doi: 10.1039/c1np00051a
– volume: 25
  start-page: 3180
  year: 2020
  ident: e_1_2_8_69_1
  article-title: Design, synthesis and anti‐tumor activity of novel benzimidazole‐chalcone hybrids as non‐intercalative topoisomerase II catalytic inhibitors
  publication-title: Biochem Pharmacol
– ident: e_1_2_8_139_1
  doi: 10.1016/j.ejmech.2013.04.023
– ident: e_1_2_8_123_1
  doi: 10.1007/s10637-013-0062-5
– ident: e_1_2_8_18_1
  doi: 10.1016/j.steroids.2008.12.007
– ident: e_1_2_8_161_1
  doi: 10.1021/acsmedchemlett.7b00545
– ident: e_1_2_8_19_1
  doi: 10.1038/nature03566
– ident: e_1_2_8_129_1
  doi: 10.1021/acs.inorgchem.8b03386
– ident: e_1_2_8_88_1
  doi: 10.1101/gad.287524.116
– ident: e_1_2_8_148_1
  doi: 10.1016/j.ejmech.2011.03.015
– ident: e_1_2_8_153_1
  doi: 10.1016/j.ejmech.2017.12.038
– ident: e_1_2_8_50_1
  doi: 10.3892/ol.2016.4606
– ident: e_1_2_8_94_1
  doi: 10.1039/B816679J
– ident: e_1_2_8_74_1
  doi: 10.1021/acs.jmedchem.7b00663
– ident: e_1_2_8_110_1
  doi: 10.1080/14756366.2017.1417274
– ident: e_1_2_8_118_1
  doi: 10.1021/acs.jmedchem.0c00343
– ident: e_1_2_8_115_1
  doi: 10.1016/j.memsci.2018.11.016
– ident: e_1_2_8_20_1
  doi: 10.1038/nature12327
– ident: e_1_2_8_157_1
  doi: 10.1016/j.ctrv.2007.08.001
– ident: e_1_2_8_125_1
  doi: 10.1021/jm200570p
– ident: e_1_2_8_144_1
  doi: 10.1111/j.1349-7006.2009.01195.x
– ident: e_1_2_8_73_1
  doi: 10.1021/acs.molpharmaceut.8b00566
– volume: 1
  start-page: 62
  year: 2011
  ident: e_1_2_8_24_1
  article-title: Dihydroartemisinin mononitrate isosorbide synthesis and in vitro anti‐tumor activity of ester conjugates
  publication-title: Synth Chem
– ident: e_1_2_8_79_1
  doi: 10.4155/fmc.09.80
– ident: e_1_2_8_32_1
  doi: 10.2174/138955711796268750
– ident: e_1_2_8_52_1
  doi: 10.18388/abp.2016_1264
– ident: e_1_2_8_68_1
  doi: 10.1039/C8MD00278A
– ident: e_1_2_8_98_1
  doi: 10.1016/j.bmc.2014.03.026
– ident: e_1_2_8_56_1
  doi: 10.1002/ardp.19963290707
– ident: e_1_2_8_71_1
  doi: 10.1016/j.ejmech.2018.02.079
– ident: e_1_2_8_120_1
  doi: 10.1039/C8CC05010D
– ident: e_1_2_8_156_1
  doi: 10.1038/cddis.2011.70
– volume: 48
  start-page: 1
  year: 2019
  ident: e_1_2_8_3_1
  article-title: Naturally occurring anti‐cancer compounds: shining from Chinese herbal medicine
  publication-title: Chin Med
– ident: e_1_2_8_22_1
  doi: 10.1039/B816679J
– ident: e_1_2_8_36_1
  doi: 10.1007/s10637-019-00767-7
– start-page: 169
  volume-title: Annual Reports in Medicinal Chemistry
  year: 1992
  ident: e_1_2_8_49_1
– ident: e_1_2_8_91_1
  doi: 10.1182/blood-2013-07-516807
– ident: e_1_2_8_87_1
  doi: 10.1021/acsomega.0c00630
– ident: e_1_2_8_13_1
  doi: 10.1016/j.bmc.2003.11.036
– ident: e_1_2_8_138_1
  doi: 10.1016/j.ejmech.2017.04.003
– volume: 16
  start-page: 1851
  year: 1996
  ident: e_1_2_8_46_1
  article-title: The activity of N‐(hydroxymethyl) melamines in fresh human ovarian tumour cells and xenografts
  publication-title: Anticancer Res
– ident: e_1_2_8_65_1
  doi: 10.1016/j.bmc.2005.02.039
– ident: e_1_2_8_47_1
  doi: 10.1023/B:BREA.0000013996.49528.d8
– ident: e_1_2_8_104_1
  doi: 10.1016/j.cbi.2019.02.002
– ident: e_1_2_8_60_1
  doi: 10.2174/092986732311160420104823
– ident: e_1_2_8_7_1
  doi: 10.1021/acs.jmedchem.8b01610
– ident: e_1_2_8_39_1
  doi: 10.1016/j.ejmech.2014.02.026
– ident: e_1_2_8_4_1
  doi: 10.1016/j.biopha.2020.111044
– ident: e_1_2_8_41_1
  doi: 10.1016/j.ejmech.2014.04.052
– ident: e_1_2_8_146_1
  doi: 10.1021/acs.jmedchem.6b00276
– ident: e_1_2_8_111_1
  doi: 10.1021/acs.jmedchem.9b00390
– volume: 3
  start-page: 183
  year: 2010
  ident: e_1_2_8_11_1
  article-title: The potential of alkaloids in drug discovery
  publication-title: Phyto Res
– ident: e_1_2_8_29_1
  doi: 10.1016/S0140-6736(19)32222-6
– ident: e_1_2_8_95_1
  doi: 10.1007/s10555-007-9064-0
– ident: e_1_2_8_114_1
  doi: 10.1039/C7CC07622C
– volume: 88
  start-page: 951
  issue: 102
  year: 2019
  ident: e_1_2_8_26_1
  article-title: Design and synthesis of the novel oleanolic acid‐cinnamic acid ester derivatives and glycyrrhetinic acid‐cinnamic acid ester derivatives with cytotoxic properties
  publication-title: Bioorg Chem
– ident: e_1_2_8_133_1
  doi: 10.1016/j.phrs.2015.10.021
– ident: e_1_2_8_140_1
  doi: 10.1016/j.ejmech.2011.09.049
– ident: e_1_2_8_99_1
  doi: 10.1016/j.ejmech.2018.02.033
– ident: e_1_2_8_137_1
  doi: 10.3390/molecules20022973
– ident: e_1_2_8_53_1
  doi: 10.2174/1871520615666150101130209
– ident: e_1_2_8_105_1
  doi: 10.1038/nrd2926
– ident: e_1_2_8_134_1
  doi: 10.1016/j.ejmech.2018.11.061
– ident: e_1_2_8_143_1
  doi: 10.1111/boc.201400004
– ident: e_1_2_8_38_1
  doi: 10.1016/j.ejmech.2016.03.087
– ident: e_1_2_8_97_1
  doi: 10.1016/j.bioorg.2019.01.026
– ident: e_1_2_8_83_1
  doi: 10.1016/j.steroids.2019.108507
– ident: e_1_2_8_77_1
  doi: 10.1002/med.21442
– ident: e_1_2_8_75_1
  doi: 10.1016/j.bioorg.2019.103382
– ident: e_1_2_8_141_1
  doi: 10.2147/DDDT.S227862
– ident: e_1_2_8_62_1
  doi: 10.1016/j.ejmech.2013.01.016
– ident: e_1_2_8_107_1
  doi: 10.1172/JCI69738
– ident: e_1_2_8_15_1
  doi: 10.2174/0929867324666170414165253
– ident: e_1_2_8_155_1
  doi: 10.1016/S0960-894X(01)00136-6
SSID ssj0011513
Score 2.5624905
SecondaryResourceType review_article
Snippet The antitumor efficacy of Chinese herbal medicines has been widely recognized. Leading compounds such as sterols, glycosides, flavonoids, alkaloids,...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1778
SubjectTerms active components
Alkaloids
Antineoplastic Agents - pharmacology
antitumor drug
Cancer
drugs combination
Drugs, Chinese Herbal - adverse effects
Flavonoids
Herbal medicine
Humans
Medicine, Chinese Traditional
R&D
Research & development
Traditional Chinese medicine
Title Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi‐active components combination
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmed.21963
https://www.ncbi.nlm.nih.gov/pubmed/37183170
https://www.proquest.com/docview/2846877023
https://www.proquest.com/docview/2813889743
Volume 43
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS-RAEG7Ekxd319eOL0oR8WDGTHeSSfAkPhDBRUTBw0LoTndE1IxMJofZ0_6D9Tf6S6zqTjK4Kix7C6RCd5J6fNVd9TVjWxJTf5X0Eg8VWHuBUGhzPA88gdE7DjEbi3JqcD7_EZ1eB2c34c0U2296YRw_RLvgRpZh_TUZuFTl3oQ0FINFl5P-oP-lWi0CRJctdRQCHXc0MibVXiR42LAK-XyvffJtLHoHMN_iVRtwTr6wn81UXZ3JfbcaqW726y8Wx_98l69stgaicOA05xubMsUc275wTNbjXbiaNGaVu7ANFxOO6_E8-3PgagdKGOQgqdW3ehwMQQ-rW6BGXyoMHcNdAaOh1HduvRHorG5TGmj28_FBDZZZFG9K63jhyTHQlqDGQDX5t2BLHl9-P9cCVAM_KKj8gy4xr7eqtcCuT46vDk-9-mwHLxOIML0I05pI5Ii3TKKl0sbIRGa-yHyJPjgPwkAYnhmuQh7EQS6oV0KbvBfnIg5MrMQimy5wtO8MQnRKmV3eFgqTfcwhjZZ-orN-ZDDBNx220_zlNKuJz-n8jYfUUTbzFF87tZ-_wzZb0SfH9vGR0GqjKmlt8GWKUT6K-31EQB220d5GU6X9F1mYQUUyPRHHmMChzJJTsXYUgRgBoZyPk7WK8vnw6fnxkb1Y_nfRFTbDcWquNm6VTY-GlVlDMDVS69ZqXgGKZh1I
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtNAEB6VcoAL_z-BAgOCikOdOru2sz5wqEirlDZVhVKpN3fXXlcR4FRxImROvAE8CK_CS_AkzO7ajsqPxKUHbpY89m7WMzvfTGa-BXguKfRXcS_2SIEzL-CKbI7lgcfJe4uQorEoNw3Oo4NoeBS8OQ6PV-Bb0wvj-CHahJuxDLtfGwM3CenNJWsoeYsuMwpUl1Tu6eojBWzlq90Bfd0XjO1sj18PvfpMAS_lhGy8iOB0xHPy8zrOpMq0lrFMfZ76kmw_D8KAa5ZqpkIWiCDnpkY_03lP5FwEWihO770El80J4oapf_C2JasiaOUOY6Yw3os4CxseI59ttlM97_1-g7TnEbJ1cTvX4XuzOK6y5V13MVfd9NMvvJH_y-rdgGs11sYtZxw3YUUXt2D90JF1Vxs4XvaelRu4jodLGu_qNnzZcuURJU5zlKabefFhOsNstjhF08tsal8rnBQ4n8ls4lKqaI4j16XGpmSBHszQkqfSTWl9C545kt0SVYWm7eAUbVXnj89fawFT5j8tTIWLuVQTl7C9A0cXslh3YbWg0e4DhrTvpjaDz1UQxRQm60z6cZb2I90XQnfgZaNWSVpzu5sjRt4njpWaJfSzE_u5O_CsFT1zhCZ_ElprdDOp97QyISATiX6fQF4Hnra3aTcyfzHJQk8XRqbHhaAYlWTuOZ1uR-EEgwit-jRZq5l_Hz4ZbQ_sxYN_F30CV4bj0X6yv3uw9xCuMpqmKwVcg9X5bKEfEXacq8fWZBFOLlrLfwKe6Hse
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3NbtQwEB6VIiEu_P8sFDAIKg7NNms7WefAoWK7aimtVqiVegt27FSrluxqsxFaTrwBvAevwlPwJIztJKvyI3HpgVukTGKvM-P5xjvzDcBziaG_SnpJgAqsA84U2hzNecDQe4sIo7E4twXO-wfxzhF_cxwdr8C3phbG80O0B27WMtx-bQ18qvPNJWkoOosutfpTZ1TumcVHjNfKV7sD_LgvKB1uH77eCeqWAkHGENgEMaLpmOXo5k2ipdLGyERmIctCiaaf84gzQzNDVUS54DmzKfra5D2RM8GNUAzfewku8zhMbJ-IwbuWqwqRle_FjFF8EDMaNTRGId1sp3re-f2GaM8DZOfhhtfhe7M2PrHltFvNVTf79Att5H-yeDfgWo20yZY3jZuwYopbsD7yVN2LDXK4rDwrN8g6GS1JvBe34cuWT44oySQn0tYyVx8mM6Jn1Qmxlcw283VBxgWZz6Qe-wNVYpuRm9KQJmEBH9TEUafiTek8C5l6it2SqAWxRQcnxOV0_vj8tRawSf6Twua32Es19se1d-DoQhbrLqwWONp9IBHuupk7v2eKxwkGyUbLMNFZPzZ9IUwHXjZalWY1s7ttMHKWek5qmuLPTt3n7sCzVnTq6Uz-JLTWqGZa72hlijAmFv0-QrwOPG1v415k_2CShZlUVqbHhMAIFWXueZVuR2EIghCrhjhZp5h_Hz7d3x64iwf_LvoErowGw_Tt7sHeQ7hKcZY-D3ANVuezyjxC4DhXj53BEnh_0Ur-E6lwec0
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Advances+of+antitumor+drug+discovery+in+traditional+Chinese+medicine+and+natural+active+products+by+using+multi-active+components+combination&rft.jtitle=Medicinal+research+reviews&rft.au=Zhao%2C+Wei&rft.au=Zheng%2C+Xiao-Di&rft.au=Tang%2C+Paula+Yun-Zhi&rft.au=Li%2C+Hong-Mei&rft.date=2023-09-01&rft.issn=1098-1128&rft.eissn=1098-1128&rft.volume=43&rft.issue=5&rft.spage=1778&rft_id=info:doi/10.1002%2Fmed.21963&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0198-6325&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0198-6325&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0198-6325&client=summon